News
The new drug has already passed Phase 1 safety trials in humans, making it a "strong candidate" for future PTSD treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback